Literature DB >> 17990357

Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis.

Tomohide Hori1, Shintaro Yagi, Taku Iida, Kentaro Taniguchi, Kentaro Yamagiwa, Chiduru Yamamoto, Takashi Hasegawa, Koichiro Yamakado, Takuma Kato, Kanako Saito, Linan Wang, Mie Torii, Yukinobu Hori, Kan Takeda, Kazuo Maruyama, Shinji Uemoto.   

Abstract

AIM: To investigate the correlation between systemic hemodynamics and splanchnic circulation in recipients with cirrhosis undergoing living-donor liver transplantation (LDLT), and to clarify how systemic hemodynamics impact on local graft circulation after LDLT.
METHODS: Systemic hemodynamics, indocyanine green (ICG) elimination rate (K ICG) and splanchnic circulation were simultaneously and non-invasively investigated by pulse dye densitometry (PDD) and ultrasound. Accurate estimators of optimal systemic hyperdynamics after LDLT [i.e., balance of cardiac output (CO) to blood volume (BV) and mean transit time (MTT), defined as the time required for half the administered ICG to pass through an attached PDD sensor in the first circulation] were also measured. Thirty recipients with cirrhosis were divided into two groups based on clinical outcomes corresponding to postoperative graft function.
RESULTS: Cirrhotic systemic hyperdynamics characterized by high CO, expanded BV and low total peripheral resistance (TPR) were observed before LDLT. TPR reflecting cirrhotic vascular alterations was slowly restored after LDLT in both groups. Although no significant temporal differences in TPR were detected between the two groups, CO/BV and MTT differed significantly. Recipients with good outcomes showed persistent cirrhotic systemic hyperdynamics after LDLT, whereas recipients with poor outcomes presented with unstable cirrhotic systemic hyperdynamics and severely decreased K ICG. Systemic hyperdynamic disorders after LDLT impacted on portal venous flow but not hepatic arterial flow.
CONCLUSION: We conclude that subtle systemic hyperdynamics disorders impact on splanchnic circulation, and that an imbalance between CO and BV decreases portal venous flow, which results in critical outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17990357      PMCID: PMC4205438          DOI: 10.3748/wjg.v13.i44.5918

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Simultaneous measurement of effective hepatic blood flow and systemic circulation.

Authors:  M Hashimoto; G Watanabe
Journal:  Hepatogastroenterology       Date:  2000 Nov-Dec

2.  Circulatory changes in chronic liver disease.

Authors:  J F MURRAY; A M DAWSON; S SHERLOCK
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

3.  Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis.

Authors:  F Piscaglia; S Gaiani; G Zironi; L Gramantieri; A Casali; S Siringo; C Serra; L Bolondi
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

4.  High cardiac output of advanced liver disease persists after orthotopic liver transplantation.

Authors:  J M Henderson; G J Mackay; M Hooks; J L Chezmar; J R Galloway; T F Dodson; M H Kutner
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

5.  Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients.

Authors:  Samir G Sakka; Konrad Reinhart; Karl Wegscheider; Andreas Meier-Hellmann
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

6.  Clinical applications of ICG Finger Monitor in patients with liver disease.

Authors:  Y Ishigami; M Masuzawa; E Miyoshi; M Kato; K Tamura; M Kanda; K Awazu; K Taniguchi; M Kurita; N Hayashi
Journal:  J Hepatol       Date:  1993-09       Impact factor: 25.083

7.  Intrahepatic hepatic vein stenosis after living-related liver transplantation treated by insertion of an expandable metallic stent.

Authors:  Kentaro Yamagiwa; Hajime Yokoi; Shuji Isaji; Masami Tabata; Shugo Mizuno; Tomohide Hori; Koichiro Yamakado; Shinji Uemoto; Kan Takeda
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

8.  Circulating blood volume measured by pulse dye-densitometry: comparison with (131)I-HSA analysis.

Authors:  T Iijima; Y Iwao; H Sankawa
Journal:  Anesthesiology       Date:  1998-12       Impact factor: 7.892

Review 9.  Cardiac abnormalities in liver cirrhosis.

Authors:  S S Lee
Journal:  West J Med       Date:  1989-11

10.  Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects.

Authors:  A Gadano; A Hadengue; J J Widmann; F Vachiery; R Moreau; S Yang; T Soupison; P Sogni; C Degott; F Durand
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

View more
  8 in total

1.  Living-donor liver transplantation for progressive familial intrahepatic cholestasis.

Authors:  Tomohide Hori; Hiroto Egawa; Aya Miyagawa-Hayashino; Tohru Yorifuji; Yukihide Yonekawa; Justin H Nguyen; Shinji Uemoto
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute.

Authors:  Naoya Yamada; Yukihiro Sanada; Yuta Hirata; Noriki Okada; Yoshiyuki Ihara; Hideki Sasanuma; Taizen Urahashi; Yasunaru Sakuma; Yoshikazu Yasuda; Koichi Mizuta
Journal:  Pediatr Surg Int       Date:  2016-01-19       Impact factor: 1.827

3.  Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization.

Authors:  Maciej Malinowski; Victoria Stary; Johan F Lock; Antje Schulz; Maximilian Jara; Daniel Seehofer; Bernhard Gebauer; Timm Denecke; Dominik Geisel; Peter Neuhaus; Martin Stockmann
Journal:  Langenbecks Arch Surg       Date:  2015-01-06       Impact factor: 3.445

4.  In vivo multispectral photoacoustic and photothermal flow cytometry with multicolor dyes: a potential for real-time assessment of circulation, dye-cell interaction, and blood volume.

Authors:  Mikhail A Proskurnin; Tatyana V Zhidkova; Dmitry S Volkov; Mustafa Sarimollaoglu; Ekaterina I Galanzha; Donald Mock; Dmitry A Nedosekin; Vladimir P Zharov
Journal:  Cytometry A       Date:  2011-09-08       Impact factor: 4.355

5.  Accuracy of arterial pressure waveform analysis for cardiac output measurement in comparison with thermodilution methods in patients undergoing living donor liver transplantation.

Authors:  Kozaburo Akiyoshi; Tadashi Kandabashi; Junko Kaji; Ken Yamaura; Hayashi Yoshimura; Kazuo Irita; Sumio Hoka
Journal:  J Anesth       Date:  2011-01-19       Impact factor: 2.078

Review 6.  Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation.

Authors:  Tomohide Hori; Yasuhiro Ogura; Yasuharu Onishi; Hideya Kamei; Nobuhiko Kurata; Motoshi Kainuma; Hideo Takahashi; Shogo Suzuki; Takashi Ichikawa; Shoko Mizuno; Tadashi Aoyama; Yuki Ishida; Takahiro Hirai; Tomoko Hayashi; Kazuko Hasegawa; Hiromu Takeichi; Atsunobu Ota; Yasuhiro Kodera; Hiroyuki Sugimoto; Taku Iida; Shintaro Yagi; Kentaro Taniguchi; Shinji Uemoto
Journal:  World J Hepatol       Date:  2016-09-08

7.  Near-infrared imaging of injured tissue in living subjects using IR-820.

Authors:  Suresh I Prajapati; Carlo O Martinez; Ali N Bahadur; Isabel Q Wu; Wei Zheng; James D Lechleiter; Linda M McManus; Gary B Chisholm; Joel E Michalek; Paula K Shireman; Charles Keller
Journal:  Mol Imaging       Date:  2009 Jan-Feb       Impact factor: 4.488

8.  Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension?

Authors:  Yuichi Takamatsu; Tomohide Hori; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Tatsuo Ito; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yusuke Kimura; Taku Kitano; Tsunehiro Yoshimura
Journal:  Am J Case Rep       Date:  2018-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.